<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Partnerships on FinanClub</title>
    <link>https://finan.club/tags/partnerships/</link>
    <description>Recent content in Partnerships on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 20 Mar 2024 09:04:43 +0000</lastBuildDate><atom:link href="https://finan.club/tags/partnerships/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>AYX</title>
      <link>https://finan.club/us/ayx/</link>
      <pubDate>Wed, 20 Mar 2024 09:04:43 +0000</pubDate>
      
      <guid>https://finan.club/us/ayx/</guid>
      <description>score:120
Chances: Alteryx&amp;rsquo;s expanded partnership and product integrations with Databricks Data Intelligence Platform provide a faster path to AI-driven insights for business users. Annual revenue climbed 13% with a notable turnaround in quarterly net income, indicating a positive trend in financial performance. The company delivered earnings and revenue surprises for the quarter ended December 2023, which may indicate positive future stock performance.</description>
    </item>
    
    <item>
      <title>BB</title>
      <link>https://finan.club/us/bb/</link>
      <pubDate>Tue, 23 Jan 2024 09:03:05 +0000</pubDate>
      
      <guid>https://finan.club/us/bb/</guid>
      <description>score:257
Chances: BlackBerry (BB) is introducing new initiatives like QNX Everywhere and QNX Sound, addressing the growing demand for skilled embedded systems developers and showcasing their commitment to innovation and growth. The collaboration with MIH Consortium and the deployment of the IVY platform for electric vehicle platform demonstrates BlackBerry&amp;rsquo;s potential for expansion in the automotive industry, a promising opportunity for future revenue growth.</description>
    </item>
    
    <item>
      <title>OGN</title>
      <link>https://finan.club/us/ogn/</link>
      <pubDate>Wed, 20 Dec 2023 09:03:44 +0000</pubDate>
      
      <guid>https://finan.club/us/ogn/</guid>
      <description>score:21
Chances: Organon&amp;rsquo;s partnership with Sempre Health to improve medication adherence shows a proactive approach to patient care and may lead to increased sales. The company&amp;rsquo;s exclusive distribution of Emgality and RAYVOW in Europe presents a significant opportunity for revenue growth in the region.</description>
    </item>
    
  </channel>
</rss>
